Exact Sciences

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of cancer. They generate revenue primarily through the sales of their flagship product, Cologuard, a non-invasive stool-based DNA test for colorectal cancer screening, and Oncotype DX, a genomic test for breast cancer. Founded in 1995, the company has grown significantly, particularly after the FDA approved Cologuard in 2014, marking a pivotal moment in its history.

Recent Posts by Exact Sciences

1-20 of 402